New Jersey pregnancy and infant health monitoring program
Official title: DP21-001 New Jersey Pregnancy Risk Assessment Monitoring System (PRAMS) - Component A: Core Surveillance
Funded at New Jersey State Dept/health/senior Srvs · NIH-11534246 · Data updated 2026-11-12
This program collects health information from New Jersey mothers and newborns to help improve prenatal care, reduce disparities, and support safer births and early parenting.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New Jersey State Dept/health/senior Srvs NIH-funded |
| Lab location | 1 site (Trenton, UNITED STATES) |
| Project start | May 1, 2021 |
| Project end | April 30, 2027 |
| Funding year | 2022 |
| Award (this year) | $175,000 |
| NIH project number | 6U01DP006622-05M004 |
| Project ID | NIH-11534246 on NIH RePORTER |
Who could benefit from this research
✓Could help
People who gave birth in New Jersey—new mothers and birthing people of any age and racial or ethnic background, with a focus on low-income and minority communities—are the intended participants.
✕Less likely to help
People who do not live in or give birth in New Jersey or those looking for direct clinical treatments are unlikely to get direct personal health benefits from participating.
What this research studies
You may be asked to answer a short questionnaire about your pregnancy, prenatal care, postpartum visits, mood, and infant care practices like sleep. The program combines these survey responses with other health records to spot groups at higher risk for poor birth outcomes. Results are used to create reports, guide local health programs, and target resources to communities in need, especially low-income and racial/ethnic minority groups. Participation usually involves mail, phone, or online contact and does not provide direct medical treatment.
Why it matters
Potential benefit: If successful, the program can guide better-targeted services and policies that improve health for mothers and babies across New Jersey.
How similar studies have gone: CDC's PRAMS surveillance has been used by many states for years and has successfully informed maternal and infant health programs and policies.
Where this research is happening
-
New Jersey State Dept/health/senior Srvs
Trenton, United States Active
Researchers
- Principal investigator: Lalanne-Raymond, Genevieve — New Jersey State Dept/health/senior Srvs
- Study coordinator: Lalanne-Raymond, Genevieve
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.